Results 51 to 60 of about 874,362 (147)

Vaccination of risk groups in England using the 13 valent pneumococcal conjugate vaccine: economic analysis. [PDF]

, 2012
OBJECTIVE: To estimate the cost effectiveness of vaccinating people with high risk conditions against invasive pneumococcal disease using the 13 valent pneumococcal conjugate vaccine.
Edmunds, W. John, van Hoek, Albert Jan, Trotter, Caroline L, Rozenbaum, Mark H., C. L. Trotter, Miller, Elizabeth, Rozenbaum, Mark H, D. Fleming, Trotter, Caroline L., E. Miller, M. H. Rozenbaum, Edmunds, W John, W. J. Edmunds, Fleming, Douglas, A. J. van Hoek   +14 more
core   +2 more sources

Surveillance of invasive pneumococcal disease in 30 EU countries: Towards a European system?

, 2010
In this era of new pneumococcal conjugate vaccines (PCV), we described and compared surveillance of invasive pneumococcal disease (IPD) and PCV policies in 30 European countries to provide guidance for Europe-wide surveillance.
Perrocheau, Anne, Celentano, Lucia Pastore, Stuart, James, de Greeffk, Sabine C, Kissling E, Lévy-Bruhl, Daniel, ECDC Country Experts for Pneumococcal Disease, Celentano LP, de Greeff, Sabine C, Tarragó, David, Stefanoff P, Amato-Gauci A, Kriz, Paula, Heuberger, Sigrid, Amato-Gauci, Andrew, Bruhl DL, Tarragó D, de Greef SC, Kriz P, Hanquet G, Kissling, Esther, ECDC country experts for pneumococcal disease, incl., Vergison A, Hanquet, Germaine, Stefanoff, Pawel, Heuberger S, Vergison, Anne, Bruhl, Daniel Levy, Perrocheau A, de Greeff, Sabine C., Stuart J, Mühlemann, Kathrin   +31 more
core   +1 more source

Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea [PDF]

Korean Journal of Pediatrics, 2011
Streptococcus pneumoniae remains a leading cause of invasive infections including bacteremia and meningitis, as well as mucosal infections such as otitis media and pneumonia among children and adults.
Eun Hwa Choi, Kyung Hyo Kim, Yae Jean Kim, Jong Hyun Kim, Su Eun Park, Hoan Jong Lee, Byung Wook Eun, Dae Sun Jo, Kyong Min Choi, Young Jin Hong   +9 more
doaj   +1 more source

Recent progress in pneumococcal protein vaccines

Frontiers in Immunology, 2023
Pneumococcal infections continue to pose a significant global health concern, necessitating the development of effective vaccines. Despite the progress shown by pneumococcal polysaccharide and conjugate vaccines, their limited coverage and the emergence ...
Sha Li, Hangeri Liang, Shui-Hao Zhao, Xiao-Yan Yang, Zhong Guo   +4 more
doaj   +1 more source

Alcoholic leukopenic pneumococcal sepsis

Avicenna Journal of Medicine, 2013
Alcohol abuse has been associated with an increased mortality and morbidity due to increased aspiration, delirium tremens, and seizures. The association of pneumococcal lung infections and leukopenia in the setting of alcohol abuse are rarely reported ...
Abdul Hamid Alraiyes, Khaldoon Shaheen, M Chadi Alraies   +2 more
doaj   +1 more source

The remaining challenges of pneumococcal disease in adults [PDF]

European Respiratory Review, 2012
Pneumococcal disease can be divided into invasive disease, i.e. when bacteria are detected in normally sterile body fluids, and noninvasive disease. Pneumococcal disease occurs more frequently in younger children and older adults.
E. Ludwig, P. Bonanni, G. Rohde, A. Sayiner, A. Torres   +4 more
doaj  

Psp140: an immunodominant antigen in the supernatant of Streptococcus pneumoniae culture

Iranian Journal of Microbiology, 2020
Background and Objectives: Streptococcus pneumoniae causes many lethal infections. Due to its reduced sensitivity to commonly used antibiotics, development of new strategies against pneumococcal infections seems to be necessary.
Davoud Afshar, Solmaz Ohadian Moghadam, Farhad Safarpoor Dehkordi, Reza Ranjbar, Amir Hasanzadeh   +4 more
doaj   +1 more source

Common NFKBIL2 polymorphisms and susceptibility to pneumococcal disease: a genetic association study. [PDF]

, 2010
INTRODUCTION: Streptococcus pneumoniae remains a major global health problem and a leading cause of death in children worldwide. The factors that influence development of pneumococcal sepsis remain poorly understood, although increasing evidence points ...
Rautanen, Anna, Moore, CE, Davies, RJ, J Scott, Adrian VS Hill, Shelley Segal, Berkley, James, Hill, Adrian, Chiea C Khor, Andrew Walley, Catrin E Moore, Hill, AVS, Peshu, N, Davies, Robert JO, Scott, John, Williams, TN, Chapman, Stephen J, James A Berkley, Segal, S, Rautanen, A, Hill, AV, Scott, J Anthony, Fredrik O Vannberg, Walley, A, Khor, Chiea C, Vannberg, Fredrik O, Davies, RJO, Khor, CC, Derrick W Crook, Crook, DW, Moore, Catrin E, Berkley, James A, Segal, Shelley, Berkley, JA, Norbert Peshu, Hill, Adrian VS, Crook, Derrick W, Thomas N Williams, Day, Nicholas P, Day, NP, Vannberg, FO, Peshu, Norbert, Chapman, SJ, Scott, JA, Stephen J Chapman, Nicholas P Day, Anna Rautanen, Williams, Thomas N, Day, Nicholas, Walley, Andrew, Williams, Thomas, Robert JO Davies   +51 more
core   +1 more source

Vaccination against pneumococcal infections in adults [PDF]

Клиническая микробиология и антимикробная химиотерапия, 2018
The following key issues of pneumococcal infection prophylaxis were discussed during the expert council: incidence rates of community-acquired pneumococcal pneumonia and other pneumococcal infections, local epidemiological data, increases in ...
Kozlov R.S., Avdeev S.N., Briko N.I., Bilichenko T.N., Kostinov M.P., Sidorenko S.V., Kharit S.M., Sinopalnikov A.I., Zaitsev A.A., Shubin I.V., Demko I.V., Ignatova G.L., Rachina S.A., Feldblum I.V.   +13 more
doaj  

Evolution of antimicrobial resistance and serotype distribution of Streptococcus pneumoniae isolated from children with invasive and noninvasive pneumococcal diseases in Algeria from 2005 to 2012

New Microbes and New Infections, 2015
Pneumococcal infections are a major cause of morbidity and mortality in developing countries. The introduction of pneumococcal conjugate vaccines (PCVs) has dramatically reduced the incidence of pneumococcal diseases. PCVs are not currently being used in
N. Ramdani-Bouguessa, H. Ziane, S. Bekhoucha, Z. Guechi, A. Azzam, D. Touati, M. Naim, S. Azrou, M. Hamidi, A. Mertani, A. Laraba, T. Annane, S. Kermani, M. Tazir   +13 more
doaj   +1 more source